BSE Live
Oct 07, 16:01Prev. Close
994.30
Open Price
1004.00
Bid Price (Qty.)
987.75 (25)
Offer Price (Qty.)
987.75 (35)
NSE Live
Oct 07, 15:57Prev. Close
994.65
Open Price
1002.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
987.90 (199)
Key Financial Ratios of Zydus Lifesciences (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 56.20 | 39.25 | 31.92 | 31.87 | 34.73 | |
Diluted EPS (Rs.) | 56.20 | 39.25 | 31.92 | 31.87 | 34.73 | |
Cash EPS (Rs.) | 71.94 | 50.65 | 42.71 | 40.97 | 42.14 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 215.84 | 174.97 | 149.60 | 130.08 | 109.30 | |
Book Value [InclRevalReserve]/Share (Rs.) | 215.84 | 174.97 | 149.60 | 130.08 | 109.30 | |
Revenue from Operations/Share (Rs.) | 422.43 | 352.73 | 310.43 | 257.67 | 226.14 | |
PBDIT/Share (Rs.) | 88.43 | 61.07 | 56.74 | 55.52 | 50.75 | |
PBIT/Share (Rs.) | 74.40 | 51.25 | 47.72 | 47.81 | 44.55 | |
PBT/Share (Rs.) | 70.58 | 46.01 | 39.49 | 38.78 | 41.14 | |
Net Profit/Share (Rs.) | 57.92 | 40.83 | 33.69 | 33.26 | 35.94 | |
NP After MI And SOA / Share (Rs.) | 56.18 | 39.24 | 31.91 | 31.87 | 34.72 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 20.93 | 17.31 | 18.27 | 21.54 | 22.44 | |
PBIT Margin (%) | 17.61 | 14.52 | 15.37 | 18.55 | 19.70 | |
PBT Margin (%) | 16.70 | 13.04 | 12.72 | 15.04 | 18.19 | |
Net Profit Margin (%) | 13.71 | 11.57 | 10.85 | 12.90 | 15.89 | |
NP After MI And SOA Margin (%) | 13.29 | 11.12 | 10.27 | 12.36 | 15.35 | |
Return on Networth/Equity (%) | 27.06 | 23.36 | 22.19 | 25.35 | 32.74 | |
Return on Capital Employed (%) | 19.89 | 15.53 | 13.89 | 15.44 | 22.25 | |
Return on Assets (%) | 12.71 | 10.06 | 8.86 | 10.23 | 15.42 | |
Total Debt/Equity (X) | 0.55 | 0.66 | 0.91 | 0.78 | 0.47 | |
Asset Turnover Ratio (%) | 95.62 | 90.45 | 86.23 | 82.72 | 100.45 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.29 | 1.23 | 1.20 | 1.28 | 1.50 | |
Quick Ratio (X) | 0.82 | 0.74 | 0.74 | 0.78 | 0.93 | |
Inventory Turnover Ratio (X) | 5.63 | 5.28 | 5.24 | 4.84 | 5.70 | |
Dividend Payout Ratio (NP) (%) | 21.35 | 22.93 | 23.50 | 23.53 | 18.00 | |
Dividend Payout Ratio (CP) (%) | 17.08 | 18.34 | 18.32 | 18.95 | 15.27 | |
Earnings Retention Ratio (%) | 78.65 | 77.07 | 76.50 | 76.47 | 82.00 | |
Cash Earnings Retention Ratio (%) | 82.92 | 81.66 | 81.68 | 81.05 | 84.73 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 22.44 | 11.64 | 5.79 | 5.30 | 13.05 | |
Interest Coverage Ratios (Post Tax) (%) | 22.44 | 11.64 | 5.79 | 5.30 | 13.05 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 37,453.76 | 22,880.77 | 17,401.45 | 17,200.05 | 17,000.22 | |
EV/Net Operating Revenue (X) | 4.33 | 3.17 | 2.74 | 3.26 | 3.67 | |
EV/EBITDA (X) | 20.68 | 18.29 | 14.97 | 15.13 | 16.36 | |
MarketCap/Net Operating Revenue (X) | 4.12 | 2.91 | 2.39 | 2.95 | 3.50 | |
Retention Ratios (%) | 78.64 | 77.06 | 76.49 | 76.46 | 81.99 | |
Price/BV (X) | 8.38 | 6.11 | 5.16 | 6.05 | 7.46 | |
Price/Net Operating Revenue | 4.12 | 2.91 | 2.39 | 2.95 | 3.50 | |
Earnings Yield | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
07.10.2025
19.09.2025
16.09.2025
10.09.2025
Zydus Life Standalone June 2025 Net Sales at Rs 2,588.30 crore, down 37.78% Y-o-Y
10.09.2025
Zydus Life Standalone June 2025 Net Sales at Rs 2,588.30 crore, down 37.78% Y-o-Y
24.06.2025
Zydus Life Consolidated March 2025 Net Sales at Rs 6,527.90 crore, up 17.96% Y-o-Y
21.05.2025
Zydus Life Standalone March 2025 Net Sales at Rs 5,819.60 crore, up 74.64% Y-o-Y
05.02.2025
Zydus Life Standalone December 2024 Net Sales at Rs 2,515.90 crore, up 6.1% Y-o-Y
12.07.2023
Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang
08.07.2022
Zydus Lifesciences Q1 PAT may dip 10.6% YoY to Rs 505.2 cr: Prabhudas Lilladher
13.01.2022
Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher
06.10.2021
Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher